Ocular Allergy Treatment Practical Impact Trial
NCT01808768
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Allergic Conjunctivitis
Rhinoconjunctivitis
Interventions
DRUG:
Alcaftadine
Sponsor
Starx Research Center, LLC